Age, Geography, and Detection Context in ACC

Epidemiology and Risk Context

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex whose epidemiologic interpretation depends heavily on age at presentation, population background, and the clinical context in which the tumor is detected.¹² Within ACC care, these features help frame pretest probability and hereditary risk rather than establish diagnosis. The broadest recurring patterns are a strong association between childhood adrenocortical tumors and germline cancer predisposition, especially TP53-related syndromes, and a geographically concentrated excess of pediatric disease in southern and southeastern Brazil related to the TP53 p.R337H founder variant.³⁴⁵

Adult ACC is more often encountered in the broader differential diagnosis of an adrenal mass, including during evaluation of adrenal incidentalomas, where benign lesions are far more common than ACC.² By contrast, a pediatric adrenocortical tumor is unusual enough that inherited susceptibility becomes a central part of the diagnostic context from the outset.¹³ Descriptive series also suggest a female predominance and somewhat younger age at diagnosis in women, although these observations are mainly population-level patterns and do not by themselves alter individual diagnostic criteria.⁶¹

The evidence base for age, geography, and detection context in ACC is limited by rarity. Most available data come from retrospective cohorts, registry analyses, narrative reviews, founder-population studies, and case reports, so the most reliable conclusions concern broad recurring associations rather than precise risk estimates that can be generalized across health systems and ancestries.⁷¹³ As a result, these epidemiologic features are best understood as modifiers of suspicion, genetic evaluation, and differential diagnosis rather than independent determinants of malignancy.

Diagnostic and epidemiologic context

ACC can occur across the lifespan, but the epidemiologic meaning of an adrenal cortical tumor differs substantially between children and adults.¹³ In adults, interpretation usually occurs within standard adrenal mass evaluation, where ACC must be distinguished from the much more common adenoma and other incidental or metastatic lesions.² In children, the rarity of adrenocortical tumors makes hereditary predisposition a more immediate consideration.

This distinction is reasonably well supported by reviews and clinical series, although exact age-specific incidence estimates vary by population.¹³ The practical implication is that age shifts the prior probability of inherited disease and the likely differential diagnosis, but it does not replace endocrine, imaging, and pathologic assessment.

Descriptive literature also reports a female predominance in ACC, with women more often presenting at younger ages and with hormone-secreting tumors.⁶¹ This pattern appears consistent enough to describe population trends, but the mechanism is uncertain and its value for individual-level decision-making is limited. Clinically, sex may inform epidemiologic context without materially changing standard evaluation pathways.

From this general context, the most clinically actionable epidemiologic question is whether age at presentation points toward hereditary susceptibility.

Age and hereditary susceptibility

Young age at diagnosis is one of the strongest epidemiologic clues that ACC may arise in the setting of an inherited cancer syndrome. Pediatric reports and reviews consistently place childhood ACC within the Li-Fraumeni spectrum and support germline TP53 testing even when family history is absent, limited, or apparently noncontributory.³⁸¹ Among the associations discussed in this note, this is one of the most reliable because it recurs across multiple study designs and populations.⁴⁵

Historical family reports support the same principle by showing ACC clustering with sarcoma, early-onset breast cancer, brain tumors, leukemia, and other malignancies across generations.⁹¹⁰ These reports are not suitable for estimating absolute risk and are vulnerable to publication bias, but they remain useful in illustrating that a brief pedigree may underestimate inherited susceptibility. In practice, pediatric ACC often functions as a sentinel tumor that prompts broader family counseling, cascade testing, and syndrome-directed surveillance.³¹¹

Other syndromic associations, including overgrowth or hamartomatous phenotypes and possible neurofibromatosis type 1 overlap, are described mainly in isolated case literature.¹²¹³ These links are much less secure than the TP53 association because causality is often uncertain and generalizability is weak. Their main clinical value is to broaden suspicion for hereditary disease when supportive phenotypic clues are present, not to define established risk categories.

Geographic variation and founder effects

The clearest geographic pattern in ACC is the markedly increased burden of pediatric adrenocortical tumors in southern and southeastern Brazil, largely attributable to the TP53 p.R337H founder variant.¹⁴⁴⁵ In that regional and ancestral context, childhood adrenocortical tumors occur far more often than in most other settings, where pediatric ACC remains exceptionally rare.¹¹⁵ This is among the best-established epidemiologic observations in ACC because molecular, clinical, and review data converge on the same explanation.⁴⁵

At the same time, founder status does not fully determine disease expression. Variable penetrance and age at diagnosis among carriers suggest that additional genetic modifiers may influence whether and when tumors develop.¹⁶ This aspect is less certain than the founder association itself, but it has an important implication: geography should be interpreted through ancestry and inherited risk rather than assumed to reflect a simple environmental cause.

Outside founder populations, geographic inference is substantially weaker. Because ACC is rare, apparent clustering may reflect referral patterns, ascertainment, or population structure rather than a true regional exposure effect.⁷ Practically, geography is most useful for identifying populations in whom hereditary evaluation should be especially prominent, not for inferring causation on its own.

This population-based perspective connects directly to how ACC enters care, since detection context changes both the comparator diagnoses and the meaning of rarity.

Detection context and mode of presentation

ACC may present through hormone excess, abdominal or flank symptoms, or imaging obtained for unrelated reasons.² In adults, incidental detection is especially important because modern imaging identifies many adrenal masses, whereas ACC remains an uncommon final diagnosis. In a large adrenal incidentaloma survey, ACC accounted for only a small minority of lesions, approximately 1.4%.²

This makes the incidentaloma setting clinically important but also potentially misleading. Larger size and atypical features may increase concern for ACC, yet incidental discovery itself is not a reliable discriminator because most incidentally detected adrenal lesions are benign.² The practical implication is that epidemiologic rarity should be incorporated into standard incidentaloma workflows rather than used as a shortcut to diagnosis.

In pediatric practice, incidental discovery is less central than symptomatic or hormonally evident presentation, and the same adrenal cortical lesion carries a different prior probability than it does in an older adult.¹³ Thus, age and detection context interact: in children, an adrenocortical tumor more strongly raises concern for hereditary susceptibility, whereas in adults the main task is often discrimination from much more common benign adrenal masses.

Limitations of inference and implications for research

Most evidence on age, geography, and detection context in ACC comes from retrospective and nonuniform sources.⁷³ These data are adequate for identifying recurring patterns, but they are less reliable for deriving precise population-level risks or for comparing regions with different referral structures, genetic backgrounds, and imaging practices. Broad qualitative conclusions are therefore more dependable than exact quantitative estimates.

Evidence for environmental causation is particularly limited. Rare-event spatial analyses are unstable, low-dose radiation cohorts contain too few ACC cases for tumor-specific conclusions, and cross-species observations do not provide dependable inference for human ACC risk.⁷¹⁷¹⁸ In practice, age, geography, and detection context are most useful for stratifying suspicion and guiding genetic evaluation, while confirmation of ACC still depends on standard endocrine, imaging, surgical, and pathologic assessment.

Overall, the literature supports a task-oriented epidemiologic view of ACC: pediatric onset most strongly suggests inherited susceptibility, founder-population geography can materially alter baseline risk, and incidental detection primarily changes the differential diagnosis rather than the underlying biology of the tumor.⁴⁵² Further progress will likely depend on multicenter registries and population-based studies that can better separate biologic variation from referral effects, ancestry, and surveillance intensity.⁷¹⁶

Included Articles

• PMID 219687: This pediatric case report discusses older literature suggesting that adrenocortical neoplasia in children may occur with increased frequency alongside congenital anomalies and hamartomatous conditions, particularly hemihypertrophy, visceral overgrowth patterns, pigmented or vascular lesions, and possibly neurofibromatosis-related syndromic overlap.¹²

• PMID 3976585: This case-based family report places adrenocortical carcinoma within a hereditary cancer syndrome characterized by sarcoma, early-onset breast cancer, brain tumors, leukemia, lung and laryngeal cancers, including both pediatric and adult ACC occurrence across generations. It emphasizes that extended multigenerational pedigree review can reveal inherited ACC risk missed by limited family history.⁹

• PMID 6577220: In two high-risk families with very early-onset breast cancer, segregation analysis supported an autosomal dominant cancer susceptibility pattern that co-occurred with brain tumors, sarcomas, leukemia, and adrenocortical carcinoma in children and young adults. The report links ACC to a hereditary multi-cancer family context rather than sporadic disease.¹⁰

• PMID 15878142: This review notes a characteristic germline TP53 codon 337 mutation, R337H, identified in children with adrenocortical carcinoma in Southern Brazil, highlighting a regional founder-effect susceptibility context for ACC. It frames this finding within Latin American cancer epidemiology and genetic risk variation.¹⁴

• PMID 19042010: A spatial analysis of 244 Israeli ACC cases from 1980 to 2005 found that ACC distribution appeared less consistent with common environmentally patterned cancers and more compatible with hereditary influences. The article also highlights the rarity and marked geographic sparsity of ACC cases, which limits conventional epidemiologic analysis.⁷

• PMID 19671334: A pediatric ACC case report identified a novel inherited TP53 germline frameshift mutation, c.522-523insG (p.R175AfsX6), present in the child and her father. The report emphasizes hereditary susceptibility in childhood ACC and its relevance for family counseling and prenatal genetic testing.⁸

• PMID 21192060: In a southeast Brazil pediatric cancer cohort, the germline TP53 R337H founder mutation was present in 65 of 70 children with adrenocortical tumors, supporting a strong hereditary risk association for pediatric adrenocortical tumors in this regional population and linking it to the broader Li-Fraumeni spectrum.⁴

• PMID 22056871: This review highlights the founder germline TP53 R337H mutation in southern Brazil as the major driver of an exceptionally high incidence of childhood adrenocortical tumors, with most tumors in young children carrying the variant. It also contrasts pediatric hereditary risk patterns with adult ACC epidemiology, including female predominance and later age at diagnosis.¹

• PMID 22233476: Childhood ACC is presented as a strong sentinel cancer for hereditary cancer risk, with the report noting that most pediatric ACC cases occur in germline TP53 mutation carriers and supporting referral for TP53 testing regardless of family cancer history. In this Malaysian case series, 3 of 4 children with ACC had germline TP53 mutations, including inherited and de novo variants.³

• PMID 23570263: This case report situates pediatric ACC within hereditary risk by describing infancy-onset ACC in a child with homozygous germline TP53 p.R337H from the Brazilian founder allele. The excerpt emphasizes the strong association of this mutation with childhood ACC and its high carrier prevalence in southern and southeastern Brazil.¹⁵

• PMID 25022788: In a retrospective series of osteosarcoma arising as a second childhood malignancy, adrenocortical carcinoma was one of the reported first primary cancers. The report places ACC within the context of hereditary and treatment-related second-cancer risk in childhood cancer survivors.¹¹

• PMID 27663983: This review highlights the Brazilian founder germline TP53 p.R337H mutation as a major hereditary risk context for pediatric ACC, with unusually high carrier frequency in Southern and Southeastern Brazil and markedly increased childhood ACC penetrance compared with the general population. It also places this mutation within the Li-Fraumeni and Li-Fraumeni-like spectrum with variable cancer risk.⁵

• PMID 31694993: In a nationwide Japanese survey of 3,672 adrenal incidentalomas, adrenocortical carcinoma accounted for 1.4% of cases and could be asymptomatic at discovery. ACC lesions were significantly larger than nonfunctioning adenomas, supporting malignancy consideration in the incidentaloma setting.²

• PMID 32147670: This study examines inherited risk modification in ACC, showing that a common SNP in ADH7 within the retinoic acid pathway was associated with earlier age at ACC diagnosis, including in TP53 p.R337H carrier cohorts and an adult ACC cohort. The article also contextualizes high pediatric ACC incidence in Southern Brazil linked to the TP53 p.R337H founder mutation and variable penetrance among carriers.¹⁶

• PMID 34063067: This review notes a female predominance in adrenocortical carcinoma, with reported female-to-male ratios of about 1.5 to 2.5 to 1. Women are also described as having a higher prevalence of secreting tumors and a younger age at diagnosis, with sex differences seen in both adult and pediatric ACC.⁶

• PMID 41797741: This case report highlights a rare but increasingly described association between neurofibromatosis type 1 and adrenocortical carcinoma, summarizing a small published case literature and noting that causality has only rarely been supported by NF1 loss-of-heterozygosity analyses. It suggests ACC should remain in the differential for adrenal incidentalomas in NF1 despite pheochromocytoma being more common.¹³

• PMID 19122398: A veterinary survey from Japan found that adrenocortical carcinoma was the most common histologic adrenal diagnosis among affected pet ferrets and that case patterns resembled North American ferret reports. Its relevance to human ACC is indirect, mainly underscoring the limits of cross-species epidemiologic comparison.¹⁸

• PMID 31342929: In a German cohort of children exposed to very low-dose postnatal diagnostic X-ray, only one adrenocortical carcinoma was observed among 100 incident cancers, and the study found no overall dose-response signal for childhood cancer. For ACC specifically, the article is informative mainly as an example of how rare-event counts constrain environmental risk inference.¹⁷

References

Footnotes

1. Molecular epidemiology of adrenocortical tumors in southern Brazil.. Mol Cell Endocrinol. 2012. PMID: 22056871. Local full text: 22056871.md ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹

2. A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features.. Endocr J. 2020. PMID: 31694993. Local full text: 31694993.md ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸

3. Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations.. Clin Genet. 2012. PMID: 22233476. Local full text: 22233476.md ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰

4. Association of the highly prevalent TP53 R337H mutation with pediatric choroid plexus carcinoma and osteosarcoma in southeast Brazil.. Cancer. 2011. PMID: 21192060. Local full text: 21192060.md ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

5. The Inherited p53 Mutation in the Brazilian Population.. Cold Spring Harb Perspect Med. 2016. PMID: 27663983. Local full text: 27663983.md ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

6. The Sexually Dimorphic Adrenal Cortex: Implications for Adrenal Disease.. Int J Mol Sci. 2021. PMID: 34063067. Local full text: 34063067.md ↩ ↩² ↩³

7. Exploratory analysis of potential risk factors of a rare disease: spatial distribution of adrenocortical carcinoma in Israel as a case study.. Sci Total Environ. 2009. PMID: 19042010. Local full text: 19042010.md ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

8. [Identification of a novel TP53 germline mutation in one child with adrenocortical carcinoma].. Zhonghua Yi Xue Za Zhi. 2009. PMID: 19671334. Local full text: 19671334.md ↩ ↩²

9. The sarcoma, breast cancer, lung cancer, and adrenocortical carcinoma syndrome revisited. Childhood cancer.. Am J Dis Child. 1985. PMID: 3976585. Local full text: 3976585.md ↩ ↩²

10. Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis.. J Natl Cancer Inst. 1983. PMID: 6577220. Local full text: 6577220.md ↩ ↩²

11. The prognosis of osteosarcoma occurring as second malignancy of childhood cancers may be favorable: experience of two cancer centers in Japan.. Int J Clin Oncol. 2015. PMID: 25022788. Local full text: 25022788.md ↩ ↩²

12. Hepatoma in a child with neurofibromatosis.. Am J Dis Child. 1979. PMID: 219687. Local full text: 219687.md ↩ ↩²

13. Rare Association Between Neurofibromatosis Type 1 and Adrenocortical Carcinoma.. Clin Case Rep. 2026. PMID: 41797741. Local full text: 41797741.md ↩ ↩²

14. TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectives.. Mutat Res. 2005. PMID: 15878142. Local full text: 15878142.md ↩ ↩²

15. TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient.. BMC Cancer. 2013. PMID: 23570263. Local full text: 23570263.md ↩ ↩²

16. A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence.. Br J Cancer. 2020. PMID: 32147670. Local full text: 32147670.md ↩ ↩² ↩³

17. Second follow-up of a German cohort on childhood cancer incidence after exposure to postnatal diagnostic x-ray.. J Radiol Prot. 2019. PMID: 31342929. Local full text: 31342929.md ↩ ↩²

18. Adrenal diseases in ferrets in Japan.. J Vet Med Sci. 2008. PMID: 19122398. Local full text: 19122398.md ↩ ↩²